Interaction between α-MSH and acetylcholinergic system upon striatal cAMP and IP3 levels

Peptides

Volumn 21, Issue 5, 2000, Pages 699-704

  Cremer, María Cecilia ^a   De Barioglio, Susana Rubiales ^a   Celis, María Ester ^a  

^a UNIVERSIDAD NACIONAL DE CÓRDOBA   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; [4 [(3 CHLOROPHENYL)CARBAMOYLOXY] 2 BUTYNYL]TRIMETHYLAMMONIUM; CYCLIC AMP; DIHYDRO BETA ERYTHROIDINE; GALLAMINE; INOSITOL 1,3,4 TRISPHOSPHATE; INTERMEDIN; MUSCARINIC AGENT; MUSCARINIC M1 RECEPTOR AGONIST; MUSCARINIC M2 RECEPTOR ANTAGONIST; MUSCARINIC RECEPTOR BLOCKING AGENT; NICOTINIC RECEPTOR BLOCKING AGENT; PILOCARPINE; PIRENZEPINE;

ANIMAL TISSUE; ARTICLE; BRAIN SLICE; CHOLINERGIC SYSTEM; CONTROLLED STUDY; CORPUS STRIATUM; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ACETYLCHOLINE; ALPHA-MSH; ANIMALS; CORPUS STRIATUM; INOSITOL 1,4,5-TRISPHOSPHATE; MALE; MUSCARINIC AGONISTS; MUSCARINIC ANTAGONISTS; NICOTINIC ANTAGONISTS; RATS; RATS, WISTAR; RECEPTORS, CHOLINERGIC;

EID: 0034129795     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-9781(00)00192-3     Document Type: Article

References (41)

1. Alger B.E., Dhanjal S.S., Dingledine R., et al. Brain slices methods. Dingladine R. Brain slices. 1984;381-437 Plenum Press, New York.
2. Arqueros L., Naquira D., Zunino E. Nicotine-induced release of catecholamines from rat hippocampus and striatum. Biochem Pharmacol. 27:1978;2667-2674.
3. Barioglio S.R., Lezcano N., Celis M.E. Alpha-MSH induced excessive grooming behavior involves a gabaergic mechanism. Peptides. 11:1990;1-3.
4. Brann M.R., Jorgensen H., Burstein E.S., et al. Structure/function relationships of muscarinic acetylcholine receptors. Life Sci. 52:1995;405-412.
5. Bredt D.S., Mourey R.J., Snyder S.H. A simple, sensitive, and specific radioreceptor assay for inositol 1,4,5-triphosphate in biological tissues. Biochem Biophys Res Commun. 159:1989;976-982.
6. Clarke P.B.S. Nicotinic receptors in mammalian brain localization and relation to cholinergic innervation . Prog Brain Res. 98:1993;77-83.
7. Cremer C., Barioglio S.R., Civallero G., Celis M.E. α-MSH -induced behavior changes after diazepam and baclofen administration related with cyclic AMP levels . Peptides. 16:1995;821-825.
8. Cremer C., Barioglio S.R., Celis M.E. Interaction between α-MSH and gabaergic agents upon striatal cAMP levels an in vitro model . Peptides. 19:1998;383-389.
9. Eberle AN. The melanotropins. Chemistry, physiology, and mechanisms of action. Basel: Karger, 1988.
10. Fisher SK. Inositol lipids and signal transduction at CNS muscarinic receptors. TIPS 1986;(suppl. II):1-5.
11. 2 receptor in vitro. Eur J Pharmacol. 207:1991;43-50.
12. 2 receptor in vitro. J Pharmacol Exp Ther. 263:1992;787-792.
13. Giorguieff-Chesselet M.F., Kemel M.L., Wandscheer D., Glowinski J. Regulation of dopamine release by presynaptic nicotine receptors in rat striatal slices effect of nicotine at low concentrations . Life Sci. 25:1979;1257-1262.
14. 4 muscarinic receptor protein in rat striatum light and electron microscopic immunocytochemistry using subtype-specific antibodies . J Neurosci. 14:1994;3351-3363.
15. Jacobowitz D.M., O′Donohue T.L. α-Melanocyte stimulating hormone immunohistochemical identification and mapping in neurons of rat brain . Proc Natl Acad Sci USA. 75:1978;6300-6304.
16. König J.F.R., Klippel R.A. The rat brain a stereotaxic atlas of the forebrain and lower parts of the brain stem . 1963;Williams & Wilkins Co, Baltimore.
17. Lezcano N., Barioglio S.R., Velez B.M., Celis M.E. Independent and simultaneous effects of α-MSH and dopamine on cyclic AMP levels in rat brain slices. Peptides. 14:1993;53-57.
18. 1 dopamine receptor. Peptides. 16:1995;133-137.
19. 1 receptor in vitro. Eur J Pharmacol. 363:1998;211-215.
20. Lichtensteiger W., Hefti F., Felix D., Huwyler T., Melamed E., Schlumpf M. Stimulation of nigrostriatal dopamine neurones by nicotine. Neuropharmacology. 21:1991;963-968.
21. Lowry O.H., Rosembrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J Biol Chem. 193:1951;265-275.
22. Marshall D., Solaikov L., Redfern P., Wonnacott S. Tetrodotoxin-sensitivity of nicotine-evoked dopamine release from rat striatum. Neuropharmacology. 35:1996;1531-1536.
23. Mc Kinney M. Muscarinic receptor subtype-specific coupling to second messengers in neuronal systems. Prog Brain Res. 98:1993;333-340.
24. O'Connor W.T., Drew K.L., Understedt U. Differential cholinergic regulation of dopamine release in the dorsal and ventral neostriatum of the rat an in vivo microdialysis study . J. Neurosci. 15:1995;8353-8361.
25. Olianas M.C., Onali P., Neff N.H., Costa E. Adenylate cyclase activity of synaptic membranes from rat striatum. Inhibition by muscarinic receptor agonists. Mol Pharmacol. 23:1983;393-398.
26. Parent A., Hazrati L. Functional anatomy of the basal ganglia. The cortico- basal ganglia- thalamo- cortical loop. Brain Res Rev. 20:1995;91-127.
27. Peralta E.G., Ashkenazi A., Winslow J.W., Smith D.H., Ramachandran J., Capon D.J. Differential regulation of PI hydrolisys and adenylate cyclase by muscarinic receptor subtypes. Nature. 334:1988;434-437.
28. 2 muscarinic receptor. Science. 236:1987;600-605.
29. 3H]dopamine from rat striatal synaptosomes. Neurosci Lett. 189:1995;171-175.
30. Sahm U.G., Qarawi M.A., Oliver G.W.J., et al. The melanocortin (MC3) receptor from rat hypothalamus photoaffinity labeling and binding of alanine-substituted α-MSH analogues . FEBS Lett. 350:1994;29-32.
31. 2 receptor. J Med Chem. 34:1991;1455-1459.
32. 1 receptor. J Med Chem. 35:1992;15-27.
33. Tatro J.B. Melanotropin receptors of the brain. Methods Neurosci. 5:1993;87-104.
34. Torre E., Celis M.E. Cholinergic mediation in the ventral tegmental area of α-melanotropin induced excessive grooming changes of the dopamine activity in the nucleus Accumbens and CP . Life Sci. 42:1988;1651-1657.
35. Torre E., Celis M.E. α-melanotropin induced excessive grooming involves brain acetylcholine possible interaction in the ventral tegmental area. APPTLA. 39:1989;49-56.
36. 1-like dopamine sites in rat striatum possible role in dopamine-mediated inositol phosphate formation . Mol Pharmacol. 48:1995;988-994.
37. Weiner D.M., Levey A.I., Brann M.R. Expression of muscarinic acetylcholine and dopamine receptor mRNAs in rat basal ganglia. Proc Natl Acad Sci USA. 87:1990;7050-7054.
38. Wess J., Blin N., Mutschler E., Blum K. Muscarinic acetylcholine receptors structural basis of ligand binding and G-protein coupling . Life Sci. 56:1995;915-922.
39. Wood P.L., Cheney D.L., Costa E. Modulation of the turnover rate of hippocampal acetylcholine by neuropeptides possible site of action of α-melanocyte stimulating hormone, adrenocorticothrophic hormone, and somatostatin . J Pharmacol. Exp Ther. 209:1979;97-103.
40. 2 muscarinic drugs on striatal dopamine release and metabolism in freely moving rats. Brain Res. 495:1989;232-242.
41. Yoshida M., Yokoo H., Tanaka T., et al. Facilitatory modulation of mesolimbic dopamine neuronal activity by a μ-opioid agonist and nicotine as examined with in vivo microdialysis. Brain Res. 624:1993;277-280.